2021 annual financial data
Akebia Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -118.44%.
Operating income was -265,318,000 USD and net income was -244,870,000 USD.
Operating cash flow was -252,965,000 USD.
Get free Akebia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 213,578,000 USD
- Operating income
- -265,318,000 USD
- Net income
- -244,870,000 USD
- Operating cash flow
- -252,965,000 USD